Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Allelic imbalance in selected chromosomal regions in ovarian cancer.

Hansen LL, Jensen LL, Dimitrakakis C, Michalas S, Gilbert F, Barber HR, Overgaard J, Arzimanoglou II.

Cancer Genet Cytogenet. 2002 Nov;139(1):1-8.

PMID:
12547149
2.

Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers.

Dorion-Bonnet F, Mautalen S, Hostein I, Longy M.

Genes Chromosomes Cancer. 1995 Nov;14(3):171-81.

PMID:
8589033
3.

Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer.

Kawakami M, Staub J, Cliby W, Hartmann L, Smith DI, Shridhar V.

Int J Oncol. 1999 Oct;15(4):715-20.

PMID:
10493953
4.

Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum.

Huang LW, Garrett AP, Muto MG, Colitti CV, Bell DA, Welch WR, Berkowitz RS, Mok SC.

Hum Pathol. 2000 Mar;31(3):367-73.

PMID:
10746681
5.

Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.

Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R.

Cancer Res. 1997 Mar 15;57(6):1058-62.

6.

Molecular genetic changes associated with ovarian cancer.

Weitzel JN, Patel J, Smith DM, Goodman A, Safaii H, Ball HG.

Gynecol Oncol. 1994 Nov;55(2):245-52.

PMID:
7959292
7.

LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.

Fiedler U, Ehlers W, Meye A, Füssel S, Faller G, Schmidt U, Wirth MP.

Anticancer Res. 2001 Jul-Aug;21(4A):2341-50.

PMID:
11724291
8.

Marked allelic imbalance on chromosome 5q31 does not explain alpha-catenin expression in epithelial ovarian cancer.

Tuhkanen H, Anttila M, Kosma VM, Puolakka J, Juhola M, Heinonen S, Mannermaa A.

Gynecol Oncol. 2004 Aug;94(2):416-21.

PMID:
15297182
9.

Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.

Davis M, Hitchcock A, Foulkes WD, Campbell IG.

Cancer Res. 1996 Feb 15;56(4):741-4.

10.

A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors.

Kalikin LM, Frank TS, Svoboda-Newman SM, Wetzel JC, Cooney KA, Petty EM.

Oncogene. 1997 Apr 24;14(16):1991-4.

11.

High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma.

Pribill I, Speiser P, Leary J, Leodolter S, Hacker NF, Friedlander ML, Birnbaum D, Zeillinger R, Krainer M.

Cancer Genet Cytogenet. 2001 Aug;129(1):23-9.

PMID:
11520561
12.

Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.

Wiper DW, Zanotti KM, Kennedy AW, Belinson JL, Casey G.

Gynecol Oncol. 1998 Oct;71(1):77-82.

PMID:
9784323
13.

High resolution allelotype of microdissected primary nasopharyngeal carcinoma.

Lo KW, Teo PM, Hui AB, To KF, Tsang YS, Chan SY, Mak KF, Lee JC, Huang DP.

Cancer Res. 2000 Jul 1;60(13):3348-53.

14.

Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.

Lee JH, Kavanagh JJ, Wildrick DM, Wharton JT, Blick M.

Cancer Res. 1990 May 1;50(9):2724-8.

15.

Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.

Bandera CA, Takahashi H, Behbakht K, Liu PC, LiVolsi VA, Benjamin I, Morgan MA, King SA, Rubin SC, Boyd J.

Cancer Res. 1997 Feb 1;57(3):513-5.

16.

[Early loss of heterozygosity on chromosome arm 16q in flat epithelial atypia of the breast. Detection by microsatellite analyses].

Schmidt H, Dahrenmöller C, Agelepoulos K, Hungermann D, Böcker W.

Pathologe. 2008 Nov;29 Suppl 2:328-32. doi: 10.1007/s00292-008-1042-y. German.

PMID:
18807038
17.

Allelic imbalance of chromosome 6q in ovarian tumours.

Orphanos V, McGown G, Hey Y, Thorncroft M, Santibanez-Koref M, Russell SE, Hickey I, Atkinson RJ, Boyle JM.

Br J Cancer. 1995 Apr;71(4):666-9.

18.

Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping.

Pesti T, Sükösd F, Jones EC, Kovacs G.

Hum Pathol. 2001 Jan;32(1):101-4.

PMID:
11172302
19.

[Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients].

Zhang H, Li Z, Chen M, Zhang G, Xu K.

Zhonghua Fu Chan Ke Za Zhi. 2002 May;37(5):298-300. Chinese.

PMID:
12133406
20.

Substantial reduction of the gastric carcinoma critical region at 6q16.3-q23.1.

Carvalho B, Seruca R, Carneiro F, Buys CH, Kok K.

Genes Chromosomes Cancer. 1999 Sep;26(1):29-34.

PMID:
10441002

Supplemental Content

Support Center